About Reletex™

The Reletex™ transdermal neuromodulation devices are the only non-invasive prescription, class II devices cleared by the FDA for use an adjunct to antiemetics in reducing postoperative nausea. The device generates a series of propoietery programmed pulses via its patented pulse generator to stimulate the median nerve on the underside of the patient’s wrist.  These pulses (specific in waveform, frequency, and intensity) create electrical signals that travel to the central nervous system and the higher emetic center in the brain. These signals act to positively modulate neural pathways, via the vagus nerve, thus restoring normal gastric rhythm.

Reletex™ is a single patient use device available in two different models: 

  • PCN-7: Seven day patient controlled therapy
  • PCN-3: Three day patient controlled  therapy 

Feature Benefit Table


*As an adjunct to anti-emetics

2. Gan TJ, Meyer T, Apfel CC, et al. Postoperative nausea and vomiting – can it be eliminated? JAMA. 2002;287:1233-1236

5. White PF, et al. Comparative efficacy of acustimulation (ReliefBand®) versus ondansetron (Zofran®) in combination with droperidol for preventing nausea and vomiting. Anesthesiol. 2002;97:1075-1081.

6.Slotnick RN. Safe, successful nausea suppression in early pregnancy with P-6 acustimulation. J Reprod Med. 2001;46:811-814.